Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of human Nav1.6 alpha subunit expressed in HEK293 cells co-expressing beta1 subunit at -35 mV holding potential by PatchXpress automated voltage clamp electrophysiology technique
Assay data:2 Active, 2 Activity ≤ 1 µM, 2 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Inhibition of Nav1.6 (unknown origin)
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Qube Assay from US Patent US11802122: "2-oxoimidazolidine-4-carboxamides as NAv1.8 inhibitors"
Assay data:104 Active, 4 Activity ≤ 1 nM, 99 Activity ≤ 1 µM, 105 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Qube Assay from US Patent US20230312528: "2-OXO-IMIDAZOLIDINE-4-CARBOXAMIDES AS NAV1.8 INHIBITORS"
Assay data:172 Active, 5 Activity ≤ 1 nM, 156 Activity ≤ 1 µM, 176 Tested
Assays for Detecting and Measuring of NaV Inhibition from US Patent US11673864: "Pyridone amides as modulators of sodium channels"
Assay data:149 Active, 1 Activity ≤ 1 nM, 112 Activity ≤ 1 µM, 159 Tested
Electrophysiological Assay (In Vitro Assay) from US Patent US11639351: "Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents"
Assay data:7 Active, 7 Activity ≤ 1 µM, 7 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
Sodium Influx Assay (In Vitro Assay) from US Patent US11639351: "Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents"
Assay data:47 Active, 28 Activity ≤ 1 µM, 48 Tested
Inhibition of human Nav 1.8 by manual electrophysiology method
Assay data:1 Active, 1 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Inhibition of human Nav1.8 by FRET based membrane potential assay
Assay data:4 Active, 1 Activity ≤ 1 µM, 5 Tested
Inhibition of human Nav1.8 channel stably expressed in HEK293 cells assessed as sodium current flow at holding potential of -90mV by whole-cell voltage clamp assay
Assay data:6 Active, 6 Activity ≤ 1 µM, 6 Tested
Inhibition of human Nav1.8 expressed in CHO cells at -120 mV holding potential by automated patch clamp electrophysiology recording
Assay data:1 Tested
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of NaV1.8 (unknown origin) cardiac ion channel by patch clamp assay
Inhibition of human Nav1.6 expressed in CHO cells by whole cell voltage clamp analysis
Inhibition of human Nav1.6 stably expressed in cells with train pulses to -20 mV at 0.1 Hz and holding potential of -85 mV by whole-cell Qube-automated patch clamp assay
Assay data:6 Active, 1 Activity ≤ 1 µM, 24 Tested
Electrophysiological Assay (In Vitro Assay) from US Patent US11325902: "Benzenesulfonamide compounds and their use as therapeutic agents"
Assay data:19 Active, 19 Activity ≤ 1 µM, 19 Tested
Electrophysiological Assay (In Vitro Assay) from US Patent US11299490: "Benzenesulfonamide compounds and their use as therapeutic agents"
Assay data:82 Active, 1 Activity ≤ 1 nM, 71 Activity ≤ 1 µM, 83 Tested
Electrophysiological Assay (In Vitro Assay) from US Patent US11174268: "Benzenesulfonamide compouds and their use as therapeutic agents"
Assay data:134 Active, 2 Activity ≤ 1 nM, 127 Activity ≤ 1 µM, 134 Tested
Sodium Influx Assay (In Vitro Assay) from US Patent US11174268: "Benzenesulfonamide compouds and their use as therapeutic agents"
Assay data:327 Active, 1 Activity ≤ 1 nM, 231 Activity ≤ 1 µM, 333 Tested
Electrophysiological Assay (In Vitro Assay) from US Patent US10981905: "Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents"
Sodium Influx Assay (In Vitro Assay) from US Patent US10981905: "Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents"
Assay data:48 Active, 28 Activity ≤ 1 µM, 49 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on